Comments Elsewhere

No rational person would invest such a huge amount of time and money into pharma if there wasnt a protection in place that made it possible for them to make a profit off of their findings.

Again, boo hoo. This is an explicitly protectionist argument, and like all protectionist arguments, the answer is: if they can’t earn a profit on their product through honest labor, without the benefit of protectionist trade barriers, then they need to think harder about their business model. Big pharma’s failed business model is their problem, not mine.